Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus
Public ClinicalTrials.gov record NCT02533570. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blinded, Placebo-controlled, Multiple-ascending-dose Study of Brentuximab Vedotin in Adults With Active Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and tolerability of brentuximab vedotin in adults with active systemic lupus erythematosus (SLE).
Study identification
- NCT ID
- NCT02533570
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2015
- Primary completion
- Jun 4, 2017
- Completion
- Jun 4, 2017
- Last update posted
- Jun 10, 2018
2015 – 2017
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham - (UAB) | Birmingham | Alabama | 35294 | — |
| TriWest Research Associates, LLC | El Cajon | California | 92020-4124 | — |
| Advanced Medical Research, LLC | La Palma | California | 90623 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Clinical Research of West Florida - Corporate | Clearwater | Florida | 33765 | — |
| Lakes Research, LLC | Miami Lakes | Florida | 33014 | — |
| Arthritis Associates | Orlando | Florida | 32804 | — |
| McIlwain Medical Group | Tampa | Florida | 33613 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Clayton Medical Associates, P.C. | St Louis | Missouri | 63117 | — |
| Weill Cornell Physicians at Brooklyn Heights | Brooklyn | New York | 11201 | — |
| DJL Clinical Research, PLLC | Charlotte | North Carolina | 28210 | — |
| Arthritis & Rheumatology Center of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| Ramesh C Gupta MD | Memphis | Tennessee | 38119 | — |
| Tekton Research, Inc. | Austin | Texas | 78745 | — |
| Accurate Clinical Research | Houston | Texas | 77034 | — |
| Arthritis Clinic of Northern Virginia, PC | Arlington | Virginia | 22205-3606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02533570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 10, 2018 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02533570 live on ClinicalTrials.gov.